These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A case report of prostate cancer with Paneth cell-like change]. Soga N, Suzuki R, Komeda Y. Hinyokika Kiyo; 1995 Nov; 41(11):891-4. PubMed ID: 8533693 [Abstract] [Full Text] [Related]
4. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior. Slovin SF. Nat Clin Pract Oncol; 2007 Sep; 4(9):551-4. PubMed ID: 17728713 [Abstract] [Full Text] [Related]
9. [Prostatic cancer with multiple pulmonary metastases treated successfully with hormonal therapy: a case report]. Fukuda M, Takashima H, Fuse H, Hirano S. Hinyokika Kiyo; 2002 Aug; 48(8):499-502. PubMed ID: 12243078 [Abstract] [Full Text] [Related]
13. [A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis]. Tsuzuki M, Kawakami S, Yonese J, Ueda T, Kageyama S, Yamauchi T, Kawai T. Hinyokika Kiyo; 1994 Sep; 40(9):837-40. PubMed ID: 7801848 [Abstract] [Full Text] [Related]
14. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma. Figg WD, Kroog G, Duray P, Walther MM, Patronas N, Sartor O, Reed E. Cancer; 1997 May 15; 79(10):1964-8. PubMed ID: 9149024 [Abstract] [Full Text] [Related]
15. Combined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long-term follow-up. Bañez LL, Blake GW, McLeod DG, Crawford ED, Moul JW. BJU Int; 2009 Aug 15; 104(3):310-4. PubMed ID: 19239458 [Abstract] [Full Text] [Related]
16. [Hormonal treatment of carcinoma of the prostate]. Obata K, Kobayashi H, Murase T, Ohisi M. Hinyokika Kiyo; 1991 Aug 15; 37(8):809-16. PubMed ID: 1720272 [Abstract] [Full Text] [Related]